Evidence map›Paper›PMID 41612464›Full record

ArticleJournal of ovarian research2026

SS-31 improves the quality of maternally aged oocytes by ameliorating mitochondrial function and metabolism.

Dongsheng Xiong, Yanan Zhang, Jiajing Wei, Li Wang, Guohui Zhang, Ling Yu, Jiuzhi Zeng, Weixin Liu

Abstract read
In one paragraph

Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dongsheng XiongKey Laboratory of Reproductive Medicine, Center of Reproductive Medicine, Sichuan Provincial Women' S and Children' S Hospital/The Affiliated Women' S and Children' S Hospital of Chengdu Medical College, Chengdu, 610045, China.
Yanan ZhangKey Laboratory of Reproductive Medicine, Center of Reproductive Medicine, Sichuan Provincial Women' S and Children' S Hospital/The Affiliated Women' S and Children' S Hospital of Chengdu Medical College, Chengdu, 610045, China.
Jiajing WeiKey Laboratory of Reproductive Medicine, Center of Reproductive Medicine, Sichuan Provincial Women' S and Children' S Hospital/The Affiliated Women' S and Children' S Hospital of Chengdu Medical College, Chengdu, 610045, China.
Li WangKey Laboratory of Reproductive Medicine, Center of Reproductive Medicine, Sichuan Provincial Women' S and Children' S Hospital/The Affiliated Women' S and Children' S Hospital of Chengdu Medical College, Chengdu, 610045, China.
Guohui ZhangCenter of Women's and Children's Health Medical Research and Technology Innovation, Sichuan Provincial Women' S and Children' S Hospital/The Affiliated Women' S and Children' S Hospital of Chengdu Medical College, Chengdu, 610045, China.
Ling YuKey Laboratory of Reproductive Medicine, Center of Reproductive Medicine, Sichuan Provincial Women' S and Children' S Hospital/The Affiliated Women' S and Children' S Hospital of Chengdu Medical College, Chengdu, 610045, China.
Jiuzhi ZengKey Laboratory of Reproductive Medicine, Center of Reproductive Medicine, Sichuan Provincial Women' S and Children' S Hospital/The Affiliated Women' S and Children' S Hospital of Chengdu Medical College, Chengdu, 610045, China.
Weixin LiuKey Laboratory of Reproductive Medicine, Center of Reproductive Medicine, Sichuan Provincial Women' S and Children' S Hospital/The Affiliated Women' S and Children' S Hospital of Chengdu Medical College, Chengdu, 610045, China. liuweixin@cmc.edu.cn.

Funding

Medical Research Project of Sichuan Medical Association S23027Sichuan Provincial Cadre Health Research Project 2024-2201Sichuan Provincial Key Laboratory/Center for Development and Regeneration 24LHFYSZ1-01Sichuan Provincial Science and Technology Program 2023YFS0057
6 · The paper itself

Abstract

Reproductive aging is closely associated with poor oocyte quality in vitro maturation, but effective approaches to ameliorate it have still not been fully determined. Here, we found that SS-31 supplementation efficaciously improved oocyte maturation and early embryonic development from aged mice. Specifically, SS-31 remarkably restored the normal spindle/chromosome structure, fertilization ability, mitochondrial distribution, ΔΨm and mitophagy in aged oocytes. In contrast, SS-31 reduced oocyte aneuploidy, ROS accumulation and DNA damage. Mechanistically, single-cell transcriptome analysis reveals that SS-31 increased the maternal mRNA degradation, and the levels of genes associated with mitochondrial function and mitophagy in aged oocytes, such as Pink1, Rps27a, Tomm7 and Map1lc3b. In addition, SS-31 suppressed chromatin organization, histone modification and chromatin remodeling pathways. Moreover, we applied the single-cell untargeted metabolomics to identify that SS-31 increased the levels of spermidine and GSH, which were critical metabolites to protect oocytes against aging. Our data reveal that the beneficial effect of SS-31 on oocyte quality from advanced age is mainly mediated by restoration of mitochondrial function, mitophagy and anti-aging metabolites. It provides a potential strategy for improving oocyte quality to extend the reproductive lifespan of female animals.

Indexed as

MitochondriaOocytesAnimalsCellular SenescenceFemaleMiceMitophagyAgingMitophagyOocyte maturationSpermidineSS-31

Identifiers

PMID41612464
PMCPMC12930897

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.